vimarsana.com

Page 171 - ஆரோக்கியம் பராமரிப்பு ஆம்ப் மருத்துவமனைகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Ensysce Biosciences, Inc And Leisure Acquisition Corp Announce Appointment Of Dave Humphrey As Chief Financial Officer

Share this article Share this article NEW YORK and SAN DIEGO, Feb. 18, 2021 /PRNewswire/ Ensysce Biosciences Inc. ( Ensysce ), a clinical stage pharmaceutical company developing medicines for severe pain relief to reduce fear of addiction, opioid misuse, abuse and overdose, and Leisure Acquisition Corp. (NASDAQ: LACQ) ( LACQ ) today announced the appointment of David Humphrey to Ensysce s management team as its Chief Financial Officer. Mr. Humphrey brings over 20 years of experience with development-stage companies as they progress toward product commercialization. Prior to joining Ensysce, Mr. Humphrey was Chief Financial Officer of Senomyx, Inc., a publicly-held biotechnology company which he led through an acquisition by Firmenich SA, a private Swiss multinational flavor and fragrance company.  As part of his responsibilities, he will oversee financial strategy and business expansion at Ensysce, in addition to assisting with Ensysce s proposed business combination with LA

Calliditas Therapeutics: Year-End Report, 2020

Share this article Share this article STOCKHOLM, Feb. 18, 2021 /PRNewswire/ On November 8, 2020, we announced positive topline readout of Part A of our Phase 3 pivotal trial, NefIgArd. The results were statistically significant and clinically relevant: proteinuria showed a 31% reduction versus baseline, a stronger effect than what was seen in the Phase 2b (27%), which is generally not expected when moving from Phase 2 to Phase 3. In addition, eGFR was stabilised in the treated patient population, which in the end is the true treatment goal. This potentially disease modifying effect is to our knowledge unique to Nefecon, which we find extremely exciting, and we look forward to our interactions with regulators during the year as we progress towards potential approval.

Teacher-Designed Barriers from LumAware s ClearGuard Series Ease School Reopening

Share this article Share this article CINCINNATI, Feb. 17, 2021 /PRNewswire/  Students and teachers are significantly safer in schools with ClearGuard Desk Guard kits to reduce infection risks, easing COVID infection fears in school districts currently holding in-person classes and those about to return to them. Designed by teachers, Desk Guards work perfectly as physical barriers, which were recommended in updated guidance from the CDC for schools. They are the latest innovation from LumAware Safety s ClearGuard series. LumAware Safety makes an entire line of safety products sold on its website lumawaresafety.com, and in Home Depot retailers nationwide via The Home Depot Pro Desk.

Chris Webber and JW Asset Management Team Up to Launch $100 Million Cannabis Impact Fund

Gaedeke Group is one of first US companies to be awarded Fitwel® Viral Response certification

Gaedeke Group is one of first US companies to be awarded Fitwel® Viral Response certification News provided by Share this article Share this article DALLAS, Feb. 16, 2021 /PRNewswire/  Gaedeke Group announces today that it is one of the first US companies to achieve Fitwel® Viral Response certification.  The company has upgraded its company systems and policies which impacts over 3 million square feet of Class A office properties in Arizona, Texas, Florida, New York and Washington, D.C. As part of our continued efforts to lead the commercial real estate industry in health and wellness, Gaedeke Group is investing in strategies and technologies that create long-term value and benefits for our customers, said Glenn Lickstein, President of Gaedeke Group, Fitwel s Viral Response certification is another sign of our commitment to building healthy and resilient environments in every city in which we operate.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.